🇺🇸 FDA
Patent

US 7485415

Sequence analysis of the tetravalent rotavirus vaccine

granted A61KA61K2039/525A61K2039/5254

Quick answer

US patent 7485415 (Sequence analysis of the tetravalent rotavirus vaccine) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/525, A61K2039/5254, A61K39/00